EPHA4 and neoplasm: In the absence of IGF1 administration, spleen enlargement was significantly decreased in EphA4‐KO tumor‐bearing mice (Fig. 3B and C), and IGF1 treatment was able to markedly increase splenic enlargement of EphA4‐KO tumor‐bearing mice.